We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Vela Technologies Plc | LSE:VELA | London | Ordinary Share | GB00BYZ9XC29 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.012 | 0.011 | 0.013 | 0.012 | 0.012 | 0.01 | 6,983,951 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investment Advice | 0 | -378k | 0.0000 | N/A | 1.63M |
Date | Subject | Author | Discuss |
---|---|---|---|
21/10/2021 18:33 | How much is Vela's £100k investment now worth? | sweepie2 | |
21/10/2021 14:34 | WeShop takeover at 25M | knowing | |
20/10/2021 15:25 | Thanks Mr white that made me chuckle. | inipvestor | |
20/10/2021 13:07 | You were right hereLook at it A shambles | jaforsadi | |
20/10/2021 13:05 | You will get news on another front I can even tell you what it is now though I can't name names just yet. Vela has taken a stake in a company that is sending a man to the moon. It will be the first human moon landing since Apollo 17 in 1972. Giving anymore away would land me in hot water for insider trading. | pwhite73 | |
20/10/2021 12:06 | However seeing as our drug trial is not commercially successful and there is no will to go to phase 3 trials then the share price could very likely drop even further.Unless we have news on another front. | inipvestor | |
20/10/2021 11:45 | Yes it is so don't be tempted in the 6s. The SGS debacle has meant they have to entice and trap at a much lower price. Don't fall for it. | pwhite73 | |
20/10/2021 09:35 | Game just start | zxie | |
18/10/2021 14:00 | 0.07p was a reasonable punt before the SGS scam not any longer. 0.04p is a safer bet. | pwhite73 | |
18/10/2021 08:30 | Choice at .07 | oakville | |
13/10/2021 11:09 | Its just a trading stock buddy for short-term price action, not overly keen as a LTH. | one_frankel | |
13/10/2021 10:34 | Yes I agree it primarily funds the technology arena although I reiterate it is not a tech company itself. I note the bid is now 60 - 65. I did warn you PIs are not going to fall for anymore SGS type scams again at 65 - 70. The company will have to lower the share price to entice quick in/out punters again. | pwhite73 | |
13/10/2021 08:43 | I see your point PWhite, maybe I should iterate that it funds the technology arena! | one_frankel | |
12/10/2021 22:34 | O_F - "Vela is predominantly a VC vehicle for 'Early Stage' tech stocks so by default its a technology stock buddy" If Vela were predominantly a VC vehicle for 'Early Stage' pharmaceutical stocks would it by default make Vela the venture capitalist company a pharmaceutical stock or would it remain a finance stock? | pwhite73 | |
12/10/2021 13:01 | Passing you the toilet paper | sweepie2 | |
10/10/2021 11:53 | Apart from diversification into the trial, Vela is predominantly a VC vehicle for 'Early Stage' tech stocks so by default its a technology stock buddy... However, I do agree with much of your other commentary except I doubt it will head much lower than the 6s. | one_frankel | |
10/10/2021 00:09 | Considering PWhite but continuing weakness in US tech is providing some reluctancy. | one_frankel | |
09/10/2021 19:50 | Are you back in at sub 0.07p?. | pwhite73 | |
09/10/2021 11:37 | I do agree to an extent PWhite but although AZD7442 is safe to use for Diabetics with long covid, it doesnt provide the necessary defence against inflammation inside the body caused by the coronavirus so its insulin resistant...I doubt its the end for AZD1656! | one_frankel | |
08/10/2021 13:23 | It's at P3 Eddy, those commercial agreements are to find a partner to fund and take it further in the latter trial. ...There is no income for Vela yet! | one_frankel |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions